ExlService Holdings, Inc. (EXLS) is currently priced at $30.83, marking a 1.5% increase from the previous close. Trading volume is at $712,210, 29.68% above the average. The asset has shown a positive price movement, reflecting active trading.
EXLS has experienced a four-day streak of price decline, with a 3.25% decrease. The streak started at $31.87, resulting in a $-1.04 absolute change.
EXLS's latest quarterly earnings report, released on April 27th, revealed earnings per share of 38 cents, slightly below the consensus estimate of 53 cents. Further details on revenue and profit margin are pending.
The company's cash flow indicates a net decrease of $13.86 million, with notable figures including free cash flow of $106.51 million and debt repayment of $56.40 million.
EXLS reported a gross profit of $209.64 million, with operating income at $78 million. Net income stands at $60.25 million, translating to earnings per share of 38 cents.
Key financial ratios show EXLS's solid performance, with a net profit margin of 11.1%, return on equity at 6.6%, and a price-to-earnings ratio of 28.36.
The balance sheet highlights total assets of $1.70 billion, with cash and cash equivalents at $146.33 million. Total liabilities amount to $789.53 million, indicating a stable financial position.
This real-time financial snapshot of EXLS provides insights into its recent performance and financial health.
ExlService Holdings, Inc. operates as a data analytics, and digital operations and solutions company in the United States and internationally. It operates through Insurance, Healthcare, Analytics, and Emerging Business segments. The company provides digital operations and solutions and analytics-driven services across the insurance industry in areas, such as claims processing, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business acquisition, policy servicing, premium audit, surveys, billing and collection, commercial and residential survey, and customer service using digital technology, artificial intelligence, machine learning, and advanced automation; digital customer acquisition services using a software-as-a-service delivery model through LifePRO and LISS platforms; subrogation services; and Subrosource software platform, an end-to-end subrogation platform. It also offers CareRadius, an integrated care management offering; and health care services related to care management, utilization management, disease management, payment integrity, revenue optimization and customer engagement to healthcare payers, providers, pharmacy benefit managers, and life sciences organizations. Further, it offers predictive and prescriptive analytics in the areas of customer acquisition and lifecycle management, risk underwriting and pricing, operational effectiveness, credit and operational risk monitoring and governance, payment integrity and care management, and data management. The company was founded in 1999 and is headquartered in New York, New York.